Controlling chemotherapy-induced emesis: Emphasis on effective and practical treatment in the outpatient setting

R. J. Gralla

Research output: Contribution to journalArticle

Abstract

EFFECTIVE antiemetic control in patients receiving cancer chemotherapy is now the standard of care. To evaluate areas for further improvement, it is necessary to assess the current degree of progress. With the use of the new serotonin antagonists (including ondansetron, granisetron, dolasetron, and tropisetron), several agents are now available in clinical practice or in trials. Clearly, complete control of emesis is an achievable goal that should be the major end-point for studies and for individual patient care.

Original languageEnglish (US)
Pages (from-to)320-323
Number of pages4
JournalCancer Bulletin
Volume47
Issue number4
StatePublished - Jan 1 1995

ASJC Scopus subject areas

  • Cancer Research

Fingerprint Dive into the research topics of 'Controlling chemotherapy-induced emesis: Emphasis on effective and practical treatment in the outpatient setting'. Together they form a unique fingerprint.

  • Cite this